Crunching the Hold-Back Numbers
Value-based purchasing and readmission hold-backs have landed, and many providers likely dont have a real firm grasp at how much money is at risk, said Raj Lakhanpal, M.D., CEO at SpectraMD USA, during a presentation at HIMSS13 in New Orleans.